Upgrade to SI Premium - Free Trial

Alnylam Pharma (ALNY)

226.15 -4.56 (1.98%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Jefferies Highlights Top Mid-Cap Biotech Stocks Ahead of Earnings October 16, 2026 6:23 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $354 at UBS October 15, 2026 9:21 AM - StreetInsider Alnylam to Webcast Conference Call Discussing Third Quarter 2026 Financial Results October 15, 2026 8:00 AM - BizWire Alnylam Pharmaceuticals (ALNY) PT Lowered to $253 at Wells Fargo October 14, 2026 6:39 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $320 at Citi October 14, 2026 5:05 AM - StreetInsider Truist Securitas's Biotechnology Earnings Preview: 'INSM, BBIO, NBIX Most Levered to the Print' October 12, 2026 9:04 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $345 at RBC Capital October 8, 2026 8:26 AM - StreetInsider Form 4 ALNYLAM PHARMACEUTICALS, For: Oct 02 Filed by: SUPRAN BRYAN October 6, 2026 4:12 PM - SEC Filing Form 144 ALNYLAM PHARMACEUTICALS, Filed by: SUPRAN BRYAN October 2, 2026 3:46 PM - SEC Filing Alnylam Pharmaceuticals (ALNY) PT Lowered to $369 at JPMorgan September 30, 2026 9:09 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) Reiterated at Neutral by Cantor Fitzgerald Amid Exciting Pipeline Inbounds September 30, 2026 6:58 AM - StreetInsider AMVUTTRA® (vutrisiran) ‘Play by Play’ Initiative Highlights Former Athletes’ Stories to Shine a Light on the Often-Missed Signs of ATTR-CM September 29, 2026 9:00 AM - BizWire Form 4 ALNYLAM PHARMACEUTICALS, For: Sep 19 Filed by: Greenstreet Yvonne September 22, 2026 4:07 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) September 21, 2026 7:29 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) September 21, 2026 7:29 AM - StreetInsider Truist Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) September 21, 2026 6:56 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) September 2, 2026 6:54 AM - StreetInsider Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26' September 1, 2026 9:07 AM - StreetInsider Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) August 31, 2026 9:20 AM - StreetInsider Truist Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) August 31, 2026 9:05 AM - StreetInsider TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) August 31, 2026 9:03 AM - StreetInsider BMO Capital on Alnylam Pharmaceuticals (ALNY): 'Strong ATTR Outlook With Limited Readthrough From Eplontersen' August 31, 2026 8:57 AM - StreetInsider Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) August 31, 2026 7:10 AM - StreetInsider Alnylam presents vutrisiran and zilebesiran data at ESC 2026 August 31, 2026 6:04 AM - StreetInsider Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings August 30, 2026 8:23 AM - BizWire Alnylam stock drops on rival heart trial: Why analysts see core business safe August 28, 2026 8:25 AM - StreetInsider Bernstein SocGen Group Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY) August 25, 2026 3:31 AM - StreetInsider Alnylam to present ATTR and hypertension data at ESC 2026 August 24, 2026 8:33 AM - StreetInsider Alnylam to Present New Data Reinforcing Strength in RNAi-Powered TTR Silencing and Continued Progress in Hypertension at ESC Congress 2026 August 24, 2026 8:33 AM - BizWire BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform August 18, 2026 4:13 PM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $256 at Wells Fargo August 14, 2026 8:51 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $455 at H.C. Wainwright August 5, 2026 6:37 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $315 at Truist Securities August 4, 2026 7:09 AM - StreetInsider Raymond James Upgrades Alnylam Pharmaceuticals (ALNY) to Strong Buy August 3, 2026 7:20 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $450 at Barclays August 3, 2026 6:39 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $375 at JPMorgan July 31, 2026 9:20 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $316 at Wells Fargo July 31, 2026 8:35 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $350 at Oppenheimer July 31, 2026 8:11 AM - StreetInsider Alnylam Pharma. (ALNY) PT Lowered; RBC Capital: 'Tough Update But Stock Reaction Looks Overdone' July 31, 2026 8:09 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $318 at Stifel July 31, 2026 8:08 AM - StreetInsider Alnylam Pharmaceuticals (ALNY) PT Lowered to $300 at Morgan Stanley July 31, 2026 8:00 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) July 31, 2026 6:41 AM - StreetInsider Form 10-Q ALNYLAM PHARMACEUTICALS, For: Jun 30 July 30, 2026 8:11 AM - SEC Filing Alnylam Pharma (ALNY) Tops Q2 EPS by 24c ; Offers Guidance July 30, 2026 8:09 AM - StreetInsider Form 8-K ALNYLAM PHARMACEUTICALS, For: Jul 30 July 30, 2026 8:06 AM - SEC Filing Alnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress July 30, 2026 8:00 AM - BizWire Full Article List